Current management strategies for warm autoimmune hemolytic anemia (wAIHA) are limited, highlighting the importance of new therapies to provide effective strategies to manage the diverse pathophysiology of wAIHA and improve outcomes in this potentially fatal disease. Tune in to this multi-accredited video-based activity to hear expert discussion on the emerging treatment landscape of wAIHA. Don’t miss this opportunity to get expert guidance on positioning the diverse mechanisms and clinical data for novel therapies in late-stage clinical investigation into personalized wAIHA management plans. This activity is delivered in partnership with wAIHA Warriors.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/faces-waiha-future-waiha-treatment-management
- Start Date: 2024-10-11 05:00:00
- End Date: 2024-10-11 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Novartis Corporation Pharmaceuticals - Amount: 37750.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest